The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1.43%3.39B | 71.92%698M | -71.56%318M | -26.10%6.47B | -49.75%1.51B | 59.42%3.44B | -87.02%406M | 137.87%1.12B | 11.14%8.75B | 31.16%3B |
Net income from continuing operations | 4,237.14%1.52B | -118.85%-285M | 22.41%519M | -1.73%5.11B | 7,022.73%3.13B | -95.11%35M | 2.51%1.51B | -85.68%424M | -58.06%5.2B | -98.73%44M |
Operating gains losses | -109.70%-23M | 87.70%-53M | 39.83%-358M | 18.03%-673M | -94.76%116M | 211.79%237M | -16.17%-431M | 75.72%-595M | 89.00%-821M | 184.02%2.21B |
Depreciation and amortization | 7.30%2.41B | 9.98%2.44B | 13.12%2.48B | 18.12%9.08B | 22.02%2.43B | 12.47%2.25B | 17.39%2.21B | 20.82%2.19B | 19.36%7.68B | 14.38%1.99B |
Asset impairment expenditure | 70.18%97M | 5.48%77M | 23.73%73M | 335.49%1.28B | 291.01%1.09B | 58.33%57M | 292.11%73M | 247.06%59M | -55.20%293M | 44.04%278M |
Unrealized gains and losses of investment securities | ---- | ---- | ---- | -141.49%-256M | ---- | ---- | ---- | ---- | --617M | ---- |
Deferred tax | -36.13%-324M | 63.58%-55M | 52.17%-44M | -569.63%-897M | -45.96%-416M | -199.17%-238M | 20.11%-151M | -121.65%-92M | -84.21%191M | -197.60%-285M |
Other non cashItems | 45.78%-456M | 113.40%160M | -398.54%-409M | -386.53%-5.74B | -90.91%-3.84B | -298.82%-841M | -326.57%-1.19B | 217.09%137M | 45.55%-1.18B | -544.37%-2.01B |
Change In working capital | -91.45%166M | 2.23%-1.58B | -93.22%-1.94B | 55.93%-1.42B | -582.47%-743M | 285.92%1.94B | -898.15%-1.62B | 53.89%-1B | -1.35%-3.23B | 112.63%154M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -1.43%3.39B | 71.92%698M | -71.56%318M | -26.10%6.47B | -49.75%1.51B | 59.42%3.44B | -87.02%406M | 137.87%1.12B | 11.14%8.75B | 31.16%3B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 25.77%-7.33B | -866.24%-8.33B | 63.37%-4.87B | 24.94%-29.76B | 22.73%-5.72B | 29.59%-9.87B | 94.46%-862M | -397.83%-13.3B | -88.41%-39.65B | 39.41%-7.41B |
Net PPE purchase and sale | -5.26%-1.98B | -35.28%-1.88B | -106.64%-2.71B | -3.81%-6.89B | -23.93%-2.32B | -8.54%-1.88B | 9.47%-1.39B | 13.06%-1.31B | -7.84%-6.64B | 4.01%-1.87B |
Net business purchase and sale | 40.63%-3.96B | -177.75%-1.46B | 92.32%-627M | 38.38%-14.47B | 54.52%-1.53B | 39.14%-6.66B | 118.80%1.88B | -1,095.00%-8.16B | -121.41%-23.48B | 65.95%-3.35B |
Net investment property transactions | 34.18%-1.07B | -119.47%-2.98B | 41.80%-1.47B | -14.68%-6.64B | -117.05%-1.15B | 32.99%-1.62B | 29.15%-1.36B | -170.94%-2.52B | -14.27%-5.79B | 71.12%-528M |
Net investment purchase and sale | -160.42%-229M | -1,686.23%-2.19B | 98.46%-24M | 55.21%-1.8B | 61.16%-759M | 9,375.00%379M | 106.83%138M | -3,018.00%-1.56B | -812.94%-4.02B | -237.99%-1.95B |
Net other investing changes | -10.34%-96M | 225.55%172M | -119.67%-48M | -85.36%41M | -92.88%21M | -108.10%-87M | -63.10%-137M | 124.28%244M | 27.27%280M | 1,440.91%295M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 25.77%-7.33B | -866.24%-8.33B | 63.37%-4.87B | 24.94%-29.76B | 22.73%-5.72B | 29.59%-9.87B | 94.46%-862M | -397.83%-13.3B | -88.41%-39.65B | 39.41%-7.41B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -28.23%4.49B | 3,332.02%7.37B | -51.62%5.21B | -38.61%19.93B | -55.87%3.13B | -43.65%6.26B | -101.74%-228M | 833.74%10.77B | 99.62%32.46B | -37.28%7.1B |
Net issuance payments of debt | 136.67%4.31B | 292.93%8.32B | -46.38%3.77B | -75.84%8.49B | -17.85%3.95B | -81.68%1.82B | -130.20%-4.31B | 14.94%7.03B | 40.57%35.14B | -56.07%4.81B |
Net common stock issuance | 67.28%-71M | -729.41%-282M | -116.67%-494M | 14.43%-575M | 48.66%-96M | -393.18%-217M | 85.34%-34M | -9.09%-228M | -94.78%-672M | -367.50%-187M |
Net preferred stock issuance | --0 | --0 | --0 | ---22M | --0 | --0 | --0 | ---22M | --0 | --0 |
Cash dividends paid | -11.33%-167M | -9.93%-166M | -9.93%-166M | 41.50%-602M | 42.31%-150M | 41.41%-150M | 41.02%-151M | 41.25%-151M | 30.75%-1.03B | -7.88%-260M |
Net other financing activities | -91.19%423M | -111.85%-506M | -49.25%2.1B | 1,386.56%12.63B | -121.03%-575M | 225.69%4.8B | 718.09%4.27B | 191.87%4.13B | 85.78%-982M | 323.88%2.73B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -28.23%4.49B | 3,332.02%7.37B | -51.62%5.21B | -38.61%19.93B | -55.87%3.13B | -43.65%6.26B | -101.74%-228M | 833.74%10.77B | 99.62%32.46B | -37.28%7.1B |
Net cash flow | ||||||||||
Beginning cash position | -9.48%11.25B | -10.02%11.74B | -22.05%11.22B | 13.41%14.4B | 6.91%12.09B | 1.82%12.43B | 10.44%13.05B | 13.41%14.4B | 27.80%12.69B | -0.33%11.31B |
Current changes in cash | 376.33%467M | 58.08%-306M | 144.39%633M | -296.57%-3.38B | -137.42%-1.05B | 76.98%-169M | -208.79%-730M | -37.78%-1.43B | -40.37%1.72B | 105.47%2.82B |
Effect of exchange rate changes | 163.16%108M | -273.15%-187M | -243.04%-113M | 1,305.88%205M | -30.77%189M | -3.64%-171M | 138.30%108M | -49.68%79M | 86.07%-17M | 1,465.00%273M |
End cash Position | -2.18%11.82B | -9.48%11.25B | -10.02%11.74B | -22.05%11.22B | -22.05%11.22B | 6.91%12.09B | 1.82%12.43B | 10.44%13.05B | 13.41%14.4B | 13.41%14.4B |
Free cash from | -48.16%663M | -35.50%-1.69B | -495.16%-2.58B | -205.74%-1.6B | -225.86%-1.2B | 509.05%1.28B | -184.81%-1.25B | 61.18%-434M | 52.57%1.52B | 473.05%955M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.